This is a working overview of AOD-9604, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-12-29. Anything still debated is marked as such rather than presented as settled.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Ubiquitin-binding domains (UBDs) are modular protein domains that non-covalently bind to ubiquitin, these motifs control various cellular events. Detailed molecular structures are known for a number of UBDs, binding specificity determines their mechanism of action and regulation, and how it regulates cellular proteins and processes.
On February 25, 2007, the Commonwealth of Virginia resolved to 'profoundly regret' and apologize for its role in the institution of slavery. Unique and the first of its kind in the U.S., the apology was unanimously passed in both Houses as Virginia approached the 400th anniversary of the founding of Jamestown. On August 24, 2007, Mayor of London Ken Livingstone issued a public apology for London's role in Atlantic slave trade, which took place at an event commemorating the 200th anniversary of the British slave trade's abolition. In his speech, Livingstone described the slave trade as "the racial murder of not just those who were transported but generations of enslaved African men, women and children. To justify this murder and torture black people had to be declared inferior or not human... We live with the consequences today." City officials in Liverpool, which was a large slave trading port, apologized in 1999. On July 30, 2008, the United States House of Representatives passed a resolution apologizing for American slavery and subsequent discriminatory laws. In June 2009, the U.S. Senate passed a resolution apologizing to African-Americans for the "fundamental injustice, cruelty, brutality, and inhumanity of slavery". The news was welcomed by President Barack Obama, the nation's first president of African descent. Some of President Obama's ancestors may have been slave owners. In 2010, Libyan leader Muammar Gaddafi apologized for Arab involvement in the slave trade, saying: "I regret the behavior of the Arabs...
== Carbon dioxide emissions == The BP Statistical Review of World Energy 2019 ranked Thailand the second highest CO2 emitter in ASEAN in 2018, estimating its emissions at 302 million tonnes. The other five largest ASEAN economies generated: Indonesia, 543 Mt; Malaysia, 250 Mt; Singapore, 230 Mt; Vietnam, 225 Mt; and Philippines, 134 Mt. In 1965, Thailand's CO2 emissions were 7.4 Mt. Global Carbon Project: In the Global Carbon Atlas 2014, of 216 nation states/territories, Thailand ranked 18 (1=most emissions, 216=fewest emissions) in CO2 emissions, up from 19 in 2013.
== History == Although genetics has its roots back in the 19th century with the work of the Bohemian monk Gregor Mendel and other pioneering scientists, human genetics emerged later. It started to develop, albeit slowly, during the first half of the 20th century. Mendelian (single-gene) inheritance was studied in a number of important disorders such as albinism, brachydactyly (short fingers and toes), and hemophilia. Mathematical approaches were also devised and applied to human genetics. Population genetics was created. Medical genetics was a late developer, emerging largely after the close of World War II (1945) when the eugenics movement had fallen into disrepute. The Nazi misuse of eugenics sounded its death knell. Shorn of eugenics, a scientific approach could be used and was applied to human and medical genetics. Medical genetics saw an increasingly rapid rise in the second half of the 20th century and continues in the 21st century.
Diagenetic monazite is the monazite that formed during or after the lithification of sedimentary rocks. Monazite has been observed to grow on other minerals or in pore spaces during diagenesis of sediments. Studying diagenetic monazite provides a good method to study the age, geochemical and thermal evolution of sedimentary basins, in particular those in the Precambrian with little fossil age controls.
Sources: en.wikipedia.org
Pearson AM and Dutson TR (1999) HACCP in Meat, Poultry and Fish Processing, Volume 10 of Advances in meat research, Springer. ISBN 978-0-8342-1327-2. Shahidi F, Jones Y and Kitts DD (1997) Seafood safety, processing, and biotechnology, Technomic, ISBN 978-1-56676-573-2. Stellman JM (ed.) (1998) Chemical, industries and occupations Volume 3 of Encyclopaedia of Occupational Health and Safety, International Labour Organization. ISBN 978-92-2-109816-4. Stewart H (1982) Indian Fishing: Early Methods on the Northwest Coast University of Washington Press. ISBN 978-0-88894-332-3. Stewart K M (1989) Fishing Sites of North and East Africa in the Late Pleistocene and Holocene. Volume 34 of Cambridge monographs in African archaeology. Stewart KM (1994) "Early hominid utilisation of fish resources and implications for seasonality and behaviour"[link removed] Journal of Human Evolution, 27: 229–245. United Nations Development Fund for Women (1993) Fish processing Food Technology Source Book Series (UNIFEM) Series, ISBN 978-1-85339-137-8.
The Canadian Armed Forces provides each soldier with a complete pre-cooked meal known as the Individual Meal Pack (IMP), packaged inside a heavy-duty folding paper bag. There are 5 breakfast menus, 6 lunch menus, and 6 supper menus. Canadian rations provide generous portions and contain a large number of commercially available items. The main meal is precooked and ready-to-eat, packed in heavy-duty plastic-foil retort pouches boxed with cardboard. Typically, the ration contains a meal item (beans and wiener sausages, scalloped potatoes with ham, smoked salmon fillet, macaroni and cheese, cheese omelette with mushrooms, shepherd's pie, etc.), wet-packed (sliced or mashed) fruit in a boxed retort pouch, and depending on the meal a combination of instant soup or cereal, fruit drink crystals, jam or cheese spread, peanut butter, honey, crackers, bread (bun) compressed into a retort pouch, coffee and tea, sugar, commercially available chocolate bars and hard candy, a long plastic spoon, paper towels and wet wipes. Canada also makes limited use of a Light Meal Pack containing dried meat or cheese, dried fruit, a granola bar, a breakfast cereal square, a chocolate bar, hard candy, hot cocoa mix, tea, and two pouches of instant fruit drink. Canadian ration packs also contain a book of cardboard matches.
== Clinical significance == Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD).
=== Leadership === Roger D. Cone began his tenure as the Mary Sue Coleman Director of the University of Michigan Life Sciences Institute in September 2016. A leading researcher in brain regulation of body weight, Cone also serves as vice provost and director of U-M's biosciences initiative. The managing director is Anna Schork. The institute's first director was Jack E. Dixon. In 2002, Mary Sue Coleman, U-M's president, appointed cell biologist and expert on insulin signaling Alan R. Saltiel as director. Saltiel served as the director until 2015, followed by interim director Stephen Weiss, who led the institute from 2015 to 2016.
== Further reading == David L. Heiserman (1968). Light -Emitting Diodes (PDF). Electronics World. Shuji Nakamura; Gerhard Fasol; Stephen J Pearton (2000). The Blue Laser Diode: The Complete Story. Springer Verlag. ISBN 978-3-540-66505-2.
Sources: en.wikipedia.org
This effect explains the extremely rapid onset of local bleeding seen in victims of Agkistrodon acutus bites. AaH I also indirectly enhances hemorrhage by interfering with platelet aggregation, because ECM fragments generated by proteolysis prevent platelets from binding properly to the injury site. This prolongs bleeding and contributes to systemic effects such as hypotension and organ ischemia. When the toxin reaches the kidneys, its proteolytic activity contributes to mesangiolysis, where the supporting mesangial cells of the glomerulus detach and die, ultimately leading to renal failure.
In 1886, Eugen Goldstein observed rays in gas discharges under low pressure that traveled away from the anode and through channels in a perforated cathode, opposite to the direction of negatively charged cathode rays (which travel from cathode to anode). Goldstein called these positively charged anode rays "Kanalstrahlen"; the standard translation of this term into English is "canal rays". Wilhelm Wien found that strong electric or magnetic fields deflected the canal rays and, in 1899, constructed a device with perpendicular electric and magnetic fields that separated the positive rays according to their charge-to-mass ratio (Q/m). Wien found that the charge-to-mass ratio depended on the nature of the gas in the discharge tube. English scientist J. J. Thomson later improved on the work of Wien by reducing the pressure to create the mass spectrograph.
The Sunni Mamluk campaigns led to the destruction of many Christian churches and monasteries and Druze sanctuaries khilwat, and caused mass destruction of Maronite and Druze villages and the killings and mass displacement of its inhabitants. In the 12th century Kisrawan had a tribal and religiously mixed population of Maronite Christians, Twelver Shia Muslims, Alawites and Druze. Information about the Christians of the Kisrawan before the 12th century is scant, though in the 9th century there was evidently an organized Christian, likely Maronite, community governed by village headmen. Under Muslim rule, Christians were mandated to pay the jizya, a form of poll tax, though its actual collection in Mount Lebanon was likely done on an inconsistent basis. The Druze religion, which branched off of Isma'ili Shia Islam in the early 11th century, and separated later from both Isma'ilism and Islam altogether, gained adherents among people in Mount Lebanon and its environs, including much of the Tanukh settlers in the hills east of Beirut. Certain aspects of the faith, such as transmigration of souls between adherents and incarnation, were viewed as heretical or kufr (infidelity) and foreign by Sunni and Shia Muslims, but contributed to solidarity among the Druze, who closed their religion to new converts in 1046 due to the threat of persecution.
Circumcision is prominent in the Hebrew Bible. In addition to proposing that circumcision was adopted by the Israelites purely as a religious mandate, scholars have suggested that Judaism's patriarchs and their followers adopted circumcision to make penile hygiene easier in hot, sandy climates; as a rite of passage into adulthood; or as a form of blood sacrifice. Historical campaigns of ethnic, cultural, and religious persecution frequently included bans on circumcision as a means of forceful assimilation, conversion, and ethnocide. Alexander the Great conquered the Middle East in the fourth century BCE, and in the following centuries ancient Greek cultures and values came to the Middle East. The Greeks abhorred circumcision, making life for circumcised Jews living among the Greeks and later the Romans very difficult. Restrictions on the Jewish practice by European governments have occurred several times in world history, including the Seleucid Empire under Antiochus IV and the Roman Empire under Hadrian, where it was used as a means of forceful assimilation and conversion. Antiochus IV's restriction on Jewish circumcision was a major factor in the Maccabean Revolt. Hadrian's prohibition has also been considered by some to have been a contributing cause of the Bar Kokhba revolt. According to Silverman (2006), these restrictions were part of a "broad campaign" by the Romans to "civilize" the Jewish people, viewing the practice as repulsive and analogous to castration. His successor, Antoninus Pius, altered the edict to permit Brit Milah.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.